キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/08/16 | 2,339 | 2,347 | 2,307 | 2,318 | -38 | -1.6% | 72,200 |
2021/08/13 | 2,327 | 2,356 | 2,327 | 2,356 | +18 | +0.8% | 52,100 |
2021/08/12 | 2,333 | 2,342 | 2,315 | 2,338 | +9 | +0.4% | 38,400 |
2021/08/11 | 2,320 | 2,333 | 2,318 | 2,329 | +21 | +0.9% | 49,300 |
2021/08/10 | 2,300 | 2,324 | 2,295 | 2,308 | +8 | +0.3% | 44,300 |
2021/08/06 | 2,283 | 2,320 | 2,283 | 2,300 | -18 | -0.8% | 49,700 |
2021/08/05 | 2,291 | 2,329 | 2,289 | 2,318 | +10 | +0.4% | 45,300 |
2021/08/04 | 2,327 | 2,337 | 2,304 | 2,308 | -29 | -1.2% | 73,100 |
2021/08/03 | 2,285 | 2,361 | 2,280 | 2,337 | +34 | +1.5% | 97,100 |
2021/08/02 | 2,257 | 2,307 | 2,255 | 2,303 | +58 | +2.6% | 79,800 |
2021/07/30 | 2,260 | 2,264 | 2,227 | 2,245 | -17 | -0.8% | 90,200 |
2021/07/29 | 2,280 | 2,283 | 2,253 | 2,262 | -1 | ±0% | 48,000 |
2021/07/28 | 2,269 | 2,279 | 2,257 | 2,263 | -30 | -1.3% | 39,600 |
2021/07/27 | 2,295 | 2,295 | 2,264 | 2,293 | +23 | +1% | 53,000 |
2021/07/26 | 2,295 | 2,299 | 2,253 | 2,270 | +1 | ±0% | 45,300 |
2021/07/21 | 2,276 | 2,290 | 2,253 | 2,269 | +11 | +0.5% | 69,800 |
2021/07/20 | 2,231 | 2,262 | 2,228 | 2,258 | +27 | +1.2% | 65,300 |
2021/07/19 | 2,228 | 2,239 | 2,211 | 2,231 | -17 | -0.8% | 71,800 |
2021/07/16 | 2,254 | 2,286 | 2,246 | 2,248 | -16 | -0.7% | 59,500 |
2021/07/15 | 2,287 | 2,300 | 2,261 | 2,264 | -26 | -1.1% | 74,600 |
2021/07/14 | 2,240 | 2,290 | 2,236 | 2,290 | +31 | +1.4% | 71,700 |
2021/07/13 | 2,240 | 2,270 | 2,239 | 2,259 | +40 | +1.8% | 97,600 |
2021/07/12 | 2,222 | 2,225 | 2,196 | 2,219 | +69 | +3.2% | 98,800 |
2021/07/09 | 2,119 | 2,151 | 2,109 | 2,150 | +11 | +0.5% | 105,000 |
2021/07/08 | 2,136 | 2,165 | 2,136 | 2,139 | -3 | -0.1% | 85,100 |
2021/07/07 | 2,132 | 2,158 | 2,122 | 2,142 | -23 | -1.1% | 56,600 |
2021/07/06 | 2,170 | 2,183 | 2,154 | 2,165 | +14 | +0.7% | 38,200 |
2021/07/05 | 2,166 | 2,166 | 2,150 | 2,151 | -22 | -1% | 44,500 |
2021/07/02 | 2,170 | 2,187 | 2,158 | 2,173 | -2 | -0.1% | 36,600 |
2021/07/01 | 2,156 | 2,186 | 2,142 | 2,175 | +22 | +1% | 72,900 |
2021/06/30 | 2,196 | 2,196 | 2,150 | 2,153 | -23 | -1.1% | 53,600 |
2021/06/29 | 2,209 | 2,213 | 2,172 | 2,176 | -54 | -2.4% | 58,600 |
2021/06/28 | 2,209 | 2,231 | 2,208 | 2,230 | -10 | -0.4% | 51,100 |
2021/06/25 | 2,234 | 2,250 | 2,219 | 2,240 | +40 | +1.8% | 97,200 |
2021/06/24 | 2,189 | 2,211 | 2,176 | 2,200 | +12 | +0.5% | 47,100 |
2021/06/23 | 2,206 | 2,209 | 2,187 | 2,188 | +6 | +0.3% | 59,600 |
2021/06/22 | 2,137 | 2,187 | 2,124 | 2,182 | +95 | +4.6% | 60,700 |
2021/06/21 | 2,146 | 2,146 | 2,082 | 2,087 | -36 | -1.7% | 88,200 |
2021/06/18 | 2,185 | 2,189 | 2,121 | 2,123 | -67 | -3.1% | 143,700 |
2021/06/17 | 2,221 | 2,221 | 2,184 | 2,190 | -29 | -1.3% | 60,900 |
2021/06/16 | 2,211 | 2,219 | 2,203 | 2,219 | -10 | -0.4% | 65,400 |
2021/06/15 | 2,200 | 2,237 | 2,188 | 2,229 | +21 | +1% | 74,800 |
2021/06/14 | 2,210 | 2,212 | 2,187 | 2,208 | +18 | +0.8% | 66,600 |
2021/06/11 | 2,185 | 2,200 | 2,175 | 2,190 | +20 | +0.9% | 101,000 |
2021/06/10 | 2,132 | 2,180 | 2,127 | 2,170 | +44 | +2.1% | 80,000 |
2021/06/09 | 2,120 | 2,148 | 2,118 | 2,126 | +9 | +0.4% | 44,000 |
2021/06/08 | 2,100 | 2,125 | 2,094 | 2,117 | +35 | +1.7% | 54,900 |
2021/06/07 | 2,115 | 2,115 | 2,080 | 2,082 | -8 | -0.4% | 46,400 |
2021/06/04 | 2,094 | 2,098 | 2,080 | 2,090 | -7 | -0.3% | 53,700 |
2021/06/03 | 2,086 | 2,116 | 2,085 | 2,097 | +11 | +0.5% | 55,100 |
1001~
1050
件表示中 / 3783件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 447,000円 | +3.6% | - | 2.68% | 15.06倍 | 0.89倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
日本新薬 | 329,300円 | +3.6% | -15.3% | 3.77% | 9.25倍 | 0.90倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
ペプチド | 173,400円 | +5.0% | +1.5% | 0.00% | 14.84倍 | 4.18倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
サンバイオ | 239,300円 | - | - | 0.00% | - | 110.84倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
科研薬 | 389,900円 | -6.4% | -71.8% | 4.87% | 43.42倍 | 0.97倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム